ALNY vs BR · P/E 76, rev $1.29B vs P/E 16, rev $7.48B
Alnylam Pharmaceuticals Inc (ALNY) versus Broadridge Financial Solutions Inc (BR) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported BR revenue for 2026-06-30 was $7.48B. Net income was $1.12B. Revenue was up 8.5% from 2025-06-30 to 2026-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Not investment advice. Open the ALNY and BR stock pages for the full models.
Not investment advice.